Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection — Stella

Home/Brain Gliomas/

View on ClinicalTrials.gov

Recruiting

Back to Brain Gliomas trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

Dushu Lake Hospital Affiliated to Soochow University, Suzhou, Jiangsu

Key details

Phase

Early testing / Safety & dosing

Sponsor

Dushu Lake Hospital Affiliated to Soochow University

Enrollment target

~25 participants

Started

June 2023

Primary completion

December 2027

Age range

18 Years – 70 Years

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.